Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperlipidemia after heart transplantation.

A Keogh1, L Simons, P Spratt

  • 1Cardiac Transplant Unit, St. Vincent's Hospital, Sydney, Australia.

The Journal of Heart Transplantation
|May 1, 1988
PubMed
Summary

Hyperlipidemia, including high cholesterol and triglycerides, is common in the first year after heart transplantation, correlating with weight gain. Weight control may help manage these lipid levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does the format matter? A cross-sectional analysis of suspected injuries and game events across the different versions of field hockey.

Frontiers in sports and active living·2025
Same author

A lanthanum bromide detector of runaway electrons for TCV.

The Review of scientific instruments·2025
Same author

Hypovolemic shock due to massive subcutaneous hemorrhage in a patient with musculocontractural Ehlers-Danlos syndrome (mcEDS).

Wiener klinische Wochenschrift·2025
Same author

Reply to Letter to the Editor: 'A phase III randomised trial on the addition of a contact x-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 years results of the OPERA trial' by J. Meyer, T. Koessler.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Prognostic Values of Pre- and Post-Therapeutic FDG-PET in Anal Canal Cancer: Analysis of a Prospective Study.

Clinical colorectal cancer·2025
Same author

A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Metabolic Disorders

Background:

  • Hyperlipidemia is a potential risk factor for late graft atherosclerosis post-heart transplantation.
  • Monitoring serum lipid levels is crucial in the first year after cardiac surgery.

Purpose of the Study:

  • To investigate serum lipid level changes in heart transplant recipients during the first year post-transplantation.
  • To assess the correlation between lipid levels, body weight, and patient characteristics.

Main Methods:

  • Serum cholesterol and triglyceride levels were measured preoperatively and up to 12 months post-transplant in 22 patients.
  • Patients were stratified into two groups based on underlying heart disease (ischemic vs. cardiomyopathy).
  • Body weight changes were tracked and correlated with lipid level fluctuations.

Related Experiment Videos

Main Results:

  • Significant increases in mean serum cholesterol and triglyceride levels were observed within the first year.
  • Hypercholesterolemia (cholesterol > 6.5 mmol/L) affected 50% of group 1 and 33% of group 2 by 12 months.
  • Hypertriglyceridemia (triglycerides > 3.0 mmol/L) was less prevalent but increased during the year.
  • Weight gain strongly correlated with elevated serum cholesterol (r=0.90) and triglycerides (r=0.84).

Conclusions:

  • Heart transplant recipients commonly develop hyperlipidemia within the first year, linked to weight gain.
  • The role of hyperlipidemia in graft atherosclerosis requires further investigation.
  • Weight management strategies should be explored for preventing or managing post-transplant hyperlipidemia.